Inhibition of contact hypersensitivity with different analogs of benzoporphyrin derivative.
暂无分享,去创建一个
J. Levy | D. Hunt | A H Chan | J G Levy | D W Hunt | G O Simkin | D E King | D. King | A. Chan | G. Simkin
[1] R. Fiel,et al. CUTANEOUS PHOTOSENSITIZING AND IMMUNOSUPPRESSIVE EFFECTS OF A SERIES OF TUMOR LOCALIZING PORPHYRINS , 1991, Photochemistry and photobiology.
[2] T. Dougherty,et al. HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.
[3] C. Bucana,et al. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. , 1990, Journal of immunology.
[4] D. Dolphin,et al. Preliminary studies on a more effective phototoxic agent than hematoporphyrin. , 1987, Journal of the National Cancer Institute.
[5] R. Keck,et al. New photosensitizers for photodynamic therapy: combined effect of metallopurpurin derivatives and light on transplantable bladder tumors. , 1988, Cancer research.
[6] R. Steinman,et al. The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.
[7] R. Grunow,et al. The Influence of Haematoporphyrin Derivative and Visible Light on Murine Skin Graft Survival, Epidermal Langerhans Cells and Stimulation of the Allogeneic Mixed Leucocyte Reaction , 1985, Scandinavian Journal of Immunology.
[8] A. Jain,et al. TARGETING ACTIVATED LYMPHOCYTES WITH PHOTODYNAMIC THERAPY: SUSCEPTIBILITY OF MITOGEN‐STIMULATED SPLENIC LYMPHOCYTES TO BENZOPORPHYRIN DERIVATIVE (BPD) PHOTOSENSITIZATION , 1995, Photochemistry and photobiology.
[9] A. Jain,et al. Photosensitising potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model. , 1991, British Journal of Cancer.
[10] D. Dolphin,et al. In vitro EVALUATION OF PHOTOTOXIC PROPERTIES OF FOUR STRUCTURALLY RELATED BENZOPORPHYRIN DERIVATIVES , 1990, Photochemistry and photobiology.
[11] S. Pelech,et al. Stimulation of Stress-activated Protein Kinase and p38 HOG1 Kinase in Murine Keratinocytes following Photodynamic Therapy with Benzoporphyrin Derivative* , 1996, The Journal of Biological Chemistry.
[12] J. Simon,et al. Low dose ultraviolet B-irradiated Langerhans cells preferentially activate CD4+ cells of the T helper 2 subset. , 1990, Journal of immunology.
[13] M. Kripke,et al. Suppression of contact hypersensitivity in mice by ultraviolet irradiation is associated with defective antigen presentation. , 1981, Immunology.
[14] M. Obochi,et al. ACTIVATION OF BENZOPORPHYRIN DERIVATIVE IN THE CIRCULATION OF MICE WITHOUT SKIN PHOTOSENSITIVITY , 1994, Photochemistry and photobiology.
[15] MOUSE SKIN PHOTOSENSITIZATION WITH BENZOPORPHYRIN DERIVATIVES AND PHOTOFRIN®: MACROSCOPIC AND MICROSCOPIC EVALUATION , 1991, Photochemistry and photobiology.
[16] J D Waterfield,et al. Photodynamic therapy; a comparison with other immunomodulatory treatments of adjuvant‐enhanced arthritis in MRL‐lpr mice , 1994, Clinical and experimental immunology.
[17] C. Elmets,et al. Immunological suppression in mice treated with hematoporphyrin derivative photoradiation. , 1986, Cancer research.
[18] J. Levy,et al. Photofrin, but not benzoporphyrin derivative, stimulates hematopoiesis in the mouse. , 1993, Immunopharmacology.
[19] R. Straight,et al. SYSTEMIC IMMUNOSUPPRESSION INDUCED BY PHOTODYNAMIC THERAPY (PDT) IS ADOPTIVELY TRANSFERRED BY MACROPHAGES , 1989, Photochemistry and photobiology.
[20] S. Aiba,et al. The ability of cultured Langerhans cells to process and present protein antigens is MHC-dependent. , 1991, Journal of immunology.
[21] J D Waterfield,et al. The use of transcutaneous photodynamic therapy in the prevention of adjuvant-enhanced arthritis in MRL/lpr mice. , 1994, Clinical immunology and immunopathology.
[22] J. Simon,et al. Low‐dose UVB radiation perturbs the functional expression of B7.1 and B7.2 co‐stimulatory molecules on human Langerhans cells , 1995, European journal of immunology.
[23] M. Udey,et al. Inhibition of epidermal Langerhans cell function by low dose ultraviolet B radiation. Ultraviolet B radiation selectively modulates ICAM-1 (CD54) expression by murine Langerhans cells. , 1991, Journal of immunology.
[24] C. Bucana,et al. Localization of DNA damage and its role in altered antigen-presenting cell function in ultraviolet-irradiated mice , 1996, The Journal of experimental medicine.
[25] J. Levy,et al. Transcutaneous Photodynamic Therapy Alters the Development of an Adoptively Transferred Form of Murine Experimental Autoimmune Encephalomyelitis , 1996, Photochemistry and photobiology.
[26] A. Enk,et al. An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin. , 1993, Journal of immunology.
[27] J. Krutmann,et al. Involvement of cytokines, DNA damage, and reactive oxygen intermediates in ultraviolet radiation-induced modulation of intercellular adhesion molecule-1 expression. , 1995, The Journal of investigative dermatology.
[28] C. Elmets,et al. Analysis of the mechanism of unresponsiveness produced by haptens painted on skin exposed to low dose ultraviolet radiation , 1983, The Journal of experimental medicine.
[29] T. Luger,et al. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. , 1995, Journal of immunology.
[30] S. Ullrich,et al. Suppression of the immune response to alloantigen by factors released from ultraviolet-irradiated keratinocytes. , 1990, Journal of immunology.
[31] Xian-Ming Pan,et al. Enhancement of the Photolysis of Nucleic Acid Monomers by Phosphates , 1997 .